Alveolar recruited macrophages contribute to lung epithelial apoptosis and barrier dysfunction by expression of TNF-related apoptosis-inducing ligand during influenza virus pneumonia Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008
Role of TNF-related apoptosis inducing ligand (TRAIL) in lung protective immunity against S. pneumoniae Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010
The role of TNF-related apoptosis inducing ligand (TRAIL) in fibrotic lung disease Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both? Year: 2011
Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL) Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer Year: 2009
Oral presentation: Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL) Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009
Effects of chemotherapeutic drugs and TRAIL (tumor necrosis factor-related apoptosis inducing ligand) on the non-small lung cancer cells Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Influenza infection of human lung macrophages increases PDL1 expression Source: Annual Congress 2013 –Viral infections Year: 2013
Rhinovirus up-regulates toll-like receptor 3 on bronchial epithelial cells and is dependent on viral replication Source: Annual Congress 2004 - Mechanisms and treatment of virus induced asthma exacerbations Year: 2004
Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of human respiratory syncytial virus infection Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection Source: Eur Respir J, 57 (6) 2003764; 10.1183/13993003.03764-2020 Year: 2021
Modulation of human macrophage IL-15 production by respiratory syncytial virus Source: Eur Respir J 2005; 26: Suppl. 49, 248s Year: 2005
Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis factor-α (TNFα) levels as a possible consequence of common TNF receptor type 2 expression Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
TNF-α inhibits human eosinophil apoptosis by activating p55 receptor and NF-κB Source: Eur Respir J 2001; 18: Suppl. 33, 162s Year: 2001
T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis Source: Eur Respir J 2011; 38: 1136-1144 Year: 2011
Dynamics of cortisol, IL-6, and the soluble IL-2 receptor in the severe influenza virus infection Source: Eur Respir J 2003; 22: Suppl. 45, 516s Year: 2003
Late-breaking abstract: Activation of the macrophage inflammasome by TLR3 ligation potentiates release of IL-8 and IP-10 from alveolar type II epithelial cells via a paracrine cytokine network Source: Annual Congress 2011 - Epithelial cells: role in health and disease Year: 2011
Human neutrophil peptides stimulate the production of TNF alpha by alveolar macrophages from patients with sarcoidosis Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007